Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Eur J Neurol ; 7(3): 255-8, 2000 May.
Article in English | MEDLINE | ID: mdl-10886308

ABSTRACT

The objective of our study was to evaluate the effects of the apolipoprotein E (ApoE) phenotype and gender on the response to tacrine treatment in Alzheimer's disease (AD). ApoE phenotyping was performed on 76 patients treated with tacrine for AD. This group comprised 33 ApoE epsilon4 allele carriers (epsilon4+) and 43 non-epsilon4 carriers (epsilon4-). Patients were treated blindly in relation to the ApoE phenotype, with incremental tacrine dosages ranging from 40 mg/day up to the highest dosage (160 mg) tolerated without side-effects. At least 6 weeks elapsed between each increase. Changes in the scores for the Alzheimer Disease Assessment Scale-Cognitive Component (ADAS-Cog) between baseline and each increment in dosage were assessed in the epsilon4- and epsilon4+ groups. The cut-off point for being considered as responsive to tacrine treatment was a 4-point decrease in the ADAS-Cog score. There was no tendency for the epsilon4- carriers to respond better than the epsilon4+ carriers. When patients were stratified by gender, no differences were found between the effects of the treatment on men and women. Consequently, these results do not support the hypothesis that the ApoE phenotype and gender are predictors of the response to tacrine in AD patients.


Subject(s)
Alleles , Alzheimer Disease/drug therapy , Alzheimer Disease/genetics , Apolipoproteins E/genetics , Cholinesterase Inhibitors/therapeutic use , Tacrine/therapeutic use , Aged , Aged, 80 and over , Alzheimer Disease/psychology , Apolipoprotein E4 , Cholinesterase Inhibitors/administration & dosage , Cognition/drug effects , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Psychiatric Status Rating Scales , Sex Characteristics , Tacrine/administration & dosage
2.
Burns ; 15(4): 257-60, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2765148

ABSTRACT

All patients hospitalized between May 1987 and June 1988 suffering from burns covering over 50 per cent of the body surface area were treated by topical application of a cream containing cerium nitrate (0.05 M) and silver sulphadiazine (0.03 M) (CN + SSD). Eleven patients were included in this series, with a mean age of 35 years (range 22-65), a mean total burn size of 78 per cent (range 50-96 per cent) and full skin thickness covering a mean of 48 per cent (range 10-91 per cent). Eight patients survived (73 per cent) (mean age 36 years; mean total burn surface 73 per cent; mean full skin thickness burn surface, 38 per cent). These results are far better than those obtained in our Unit where a survival rate of 34 per cent was obtained in a comparable series of patients treated before 1987. Sixty positive blood cultures were obtained, which included a large variety of organisms with a slight predominance of Staph. aureus, Candida albicans and Ps. aeruginosa. Wound cultures were positive in 72 per cent of swabs and showed a predominance of Ps. aeruginosa (59 per cent of all the strains isolated). Even if CN + SSD appears in this series not to be very efficient in preventing wound colonization and septic complications, it permitted a very high survival rate in the treated patients, taking into account the extreme severity of the injuries. This beneficial effect is probably the consequence of the protective action of the yellow-green eschar formed by CN + SSD.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Anti-Infective Agents, Local/therapeutic use , Burns/drug therapy , Cerium/therapeutic use , Silver Sulfadiazine/therapeutic use , Sulfadiazine/therapeutic use , Administration, Cutaneous , Adult , Aged , Anti-Infective Agents, Local/administration & dosage , Bandages , Body Surface Area , Burns/mortality , Burns/pathology , Cerium/administration & dosage , Female , Humans , Male , Middle Aged , Sepsis/prevention & control , Silver Sulfadiazine/administration & dosage , Therapeutic Irrigation
4.
Contracept Fertil Sex (Paris) ; 9(9): 551-4, 1981 Sep.
Article in French | MEDLINE | ID: mdl-12337642

ABSTRACT

PIP: 247 women using local contraception with a vaginal tampon impregnated with benzalkonium chloride were observed for 2597 cycles; there was only 1 pregnancy. After accurate anamnesis it appeared that the patient had neutralized the cationic spermicidal agent through postcoital douching with a liquid anoionic soap. The use of tensioactive agents in products for female hygiene is widespread, since they have active foaming and detergent properties. Spermicidal vaginal agents must never be diluted by a vaginal douche, or modified by chemical products with antagonizing properties. The use of tensioactive anionic products for female hygiene and their contact with spermicidal cationic ammonium derivates, results in the deactivation of such derivates, while nonanionic tensioactives provoke no action on cationic spermicidal agents. This brief article includes a list of different types of tensioactives, and divides them in anionic, cationic, and nonanionic categories.^ieng


Subject(s)
Contraception , Evaluation Studies as Topic , Spermatocidal Agents , Tampons, Surgical , Contraception Behavior , Contraceptive Agents , Contraceptives, Postcoital , Equipment and Supplies , Family Planning Services
SELECTION OF CITATIONS
SEARCH DETAIL
...